The DOI matches its Crossref record.
IL-12-induced IL-10 production by human T cells as a negative feedback for IL-12-induced immune responses
Abstract
IL-12 is an important initiator of cellular immune responses. This involves a positive feedback mechanism via IFN-γ, which is abrogated when the pathogen that induces IL-12 production by the macrophage has been cleared. Here, we studied IL-10 as an additional negative regulator of IL-12-induced immune responses. Our results showed that upon stimulation with CD2 mAb, IL-12 was capable of inducing human T cells to produce IL-10. IL-12 was able to induce IL-10 production in primary T cells in the absence or the presence of accessory cells and in short-term cultures of established T cell clones. Moreover, T cell clones that had been cultured for longer periods in the presence of IL-12, when restimulated in the absence of IL-12, still produced high amounts of IL-10. Furthermore, we demonstrated that IL-10-mediated inhibition of T cell proliferation was dose dependent and depended on the time of addition of IL-10 and on the IL-12 concentration in culture. IL-10 has been identified as a dominant inhibitor of IL-12 production by APCs. The finding that IL-12 is capable of potently inducing its own inhibitor shows that the immune system is equipped with an intrinsic negative feedback mechanism that limits ongoing T cell activation. This indicates that the kinetics of T cell responses seem to be regulated by the ratio of IL-12 and IL-10 levels, which may gradually decline during the immune response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
The regulation of IL-10 production by immune cells
Saraiva, M., & O'Garra, A. (2010) · Nature Reviews Immunology · doi:10.1038/nri2711 · Cited by 3,164
IL-10: The Master Regulator of Immunity to Infection
Couper, K. N., Blount, D. G., & Riley, E. M. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.9.5771 · Cited by 2,223
Regulation and Functions of the IL-10 Family of Cytokines in Inflammation and Disease
Ouyang, W., Rutz, S., Crellin, N. K., Valdez, P. A., & Hymowitz, S. G. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101312 · Cited by 1,925
THE INTERLEUKIN-12/INTERLEUKIN-12-RECEPTOR SYSTEM: Role in Normal and Pathologic Immune Responses
Gately, M. K., Renzetti, L. M., Magram, J., Stern, A. S., Adorini, L., Gubler, U., & Presky, D. H. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.495 · Cited by 1,231
Interleukin-12: A Cytokine at the Interface of Inflammation and Immunity
Trinchieri, G. (1998) · Advances in Immunology · doi:10.1016/s0065-2776(08)60387-9 · Cited by 760
TH1 cells control themselves by producing interleukin-10
O'Garra, A., & Vieira, P. (2007) · Nature Reviews Immunology · doi:10.1038/nri2097 · Cited by 617
Interleukin-12: Biological Properties and Clinical Application
Del Vecchio, M., Bajetta, E., Canova, S., Lotze, M. T., Wesa, A., Parmiani, G., & Anichini, A. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0776 · Cited by 601
Anderson, C. F., Oukka, M., Kuchroo, V. J., & Sacks, D. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061886 · Cited by 571
New insights into IL-12-mediated tumor suppression
Tugues, S., Burkhard, S. H., Ohs, I., Vrohlings, M., Nussbaum, K., vom Berg, J., Kulig, P., & Becher, B. (2015) · Cell Death & Differentiation · doi:10.1038/cdd.2014.134 · Cited by 558
Regulatory T Cells in the Control of Host-Microorganism Interactions
Belkaid, Y., & Tarbell, K. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132723 · Cited by 468
Strategies for use of IL‐10 or its antagonists in human disease
O'Garra, A., Barrat, F. J., Castro, A. G., Vicari, A., & Hawrylowicz, C. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00635.x · Cited by 452
Zhang, L., Morgan, R. A., Beane, J. D., Zheng, Z., Dudley, M. E., Kassim, S. H., Nahvi, A. V., Ngo, L. T., Sherry, R. M., Phan, G. Q., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2085 · Cited by 444
High-level IL-12 production by human dendritic cells requires two signals
Snijders, A. (1998) · International Immunology · doi:10.1093/intimm/10.11.1593 · Cited by 420
Diversity in the contribution of interleukin‐10 to T‐cell‐mediated immune regulation
Maynard, C. L., & Weaver, C. T. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00711.x · Cited by 402
Immunodeficiency Diseases Caused by Defects in Phagocytes
Lekstrom-Himes, J. A., & Gallin, J. I. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012073432307 · Cited by 390
Type 1 and Type 2 Cytokine Imbalance in Acute Respiratory Syncytial Virus Bronchiolitis
Legg, J. P., Hussain, I. R., Warner, J. A., Johnston, S. L., & Warner, J. O. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200210-1148oc · Cited by 390
Cytokines acting on or secreted by macrophages during intracellular infection (IL-10, IL-12, IFN-γ)
Trinchieri, G. (1997) · Current Opinion in Immunology · doi:10.1016/s0952-7915(97)80154-9 · Cited by 338
Huber, V. C., Lynch, J. M., Bucher, D. J., Le, J., & Metzger, D. W. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.12.7381 · Cited by 319
Saraiva, M., Christensen, J. R., Veldhoen, M., Murphy, T. L., Murphy, K. M., & O'Garra, A. (2009) · Immunity · doi:10.1016/j.immuni.2009.05.012 · Cited by 315
Hessle, C., Andersson, B., & Wold, A. E. (2000) · Infection and Immunity · doi:10.1128/iai.68.6.3581-3586.2000 · Cited by 311
Current status of interleukin-10 and regulatory T-cells in cancer
Dennis, K. L., Blatner, N. R., Gounari, F., & Khazaie, K. (2013) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000006 · Cited by 289
Proinflammatory and Immunoregulatory Functions of Interleukin-12
Trinchieri, G. (1998) · International Reviews of Immunology · doi:10.3109/08830189809043002 · Cited by 290
McKinstry, K. K., Strutt, T. M., Buck, A., Curtis, J. D., Dibble, J. P., Huston, G., Tighe, M., Hamada, H., Sell, S., Dutton, R. W., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900657 · Cited by 287
Regulation of IL-10 and IL-12 production and function in macrophages and dendritic cells
Ma, X., Yan, W., Zheng, H., Du, Q., Zhang, L., Ban, Y., Li, N., & Wei, F. (2015) · F1000Research · doi:10.12688/f1000research.7010.1 · Cited by 272
Tuning Microenvironments: Induction of Regulatory T Cells by Dendritic Cells
Belkaid, Y., & Oldenhove, G. (2008) · Immunity · doi:10.1016/j.immuni.2008.08.005 · Cited by 268
Type I IFNs Inhibit Human Dendritic Cell IL-12 Production and Th1 Cell Development
McRae, B. L., Semnani, R. T., Hayes, M. P., & van Seventer, G. A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.9.4298 · Cited by 260
Interleukin-10 potential benefits and possible risks in clinical infectious diseases
Opal, S. M., Wherry, J. C., & Grint, P. (1998) · Clinical Infectious Diseases · doi:10.1086/515032 · Cited by 114
“Moreover, IL-10 is a potent inhibitor of IL-12, IFN-y, nitric oxide, and the THI-type cytokines IFNy and TNF [38, 53-58].”
BackgroundCD4 + T Cells: Guardians of the Phagosome
Tubo, N. J., & Jenkins, M. K. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00097-13 · Cited by 105
De Palma, G., Cinova, J., Stepankova, R., Tuckova, L., & Sanz, Y. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0709471 · Cited by 90
Ashraf, R., Vasiljevic, T., Day, S. L., Smith, S. C., & Donkor, O. N. (2014) · Journal of Functional Foods · doi:10.1016/j.jff.2013.11.006 · Cited by 62
Metadata
- Authors
- Meyaard, L., Hovenkamp, E., Otto, S. A., & Miedema, F.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1996-04
- Volume
- 156
- Issue
- 8
- Pages
- 2776-2782
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1755667520
- Cited by
- 207
- References
- 0
- FWCI
- 8.49
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.